Mandate

Vinge advises Borgo AB in connection with issuance of covered bonds

September 15, 2021 Banking and Finance

Vinge has advised Borgo in connection with the issue of a SEK 5,5 billion covered bond by Ålandsbanken Abp as initial issuer and Borgo as subsequent issuer.

The terms and conditions of the covered bonds allow covered bonds to be transferred to Borgo AB at a later stage subject to the approval of Ålandsbanken Abp and Borgo.

Borgo is an independent mortgage lending company aiming to offer market leading mortgages to Swedish consumers. Borgo’s mortgage products will be offered by ICA Banken, Ikano Bank, Söderberg & Partners and Ålandsbanken, under their brands but with Borgo as lender.

Vinge’s team mainly consisted of Mikael Ståhl, Lionardo Ojeda, Axel Jansson and Felix Möller.

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026